Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

Lung Cancer Test Predicts Survival in Early Stages ... Experimental mRNA Cancer Vaccine Shows Potential for Advanced Stage Cancer Patients in Phase 1 Trial Sep. 13, 2024 — Interim data from ...

Tagrisso is associated with positive outcomes among patients with unresectable stage 3 EGFR-mutant non-small cell lung cancer ...

Patient and caregiver engagement interventions show significant potential for improving lung cancer outcomes, according to a systematic review in Lung Cancer.

Hillcrest Medical Center displayed new advanced technology in a thoracic oncology mobile experience aimed at educating patients on the advancements made in diagnosing and treating lung cancer.

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.

Researchers evaluated billing for early palliative care among Medicare beneficiaries who were newly diagnosed with 1 of 6 common distant-stage cancers.

In April 2025, Amgen announced a study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose ...

The institute uses assistance from AI to detect lung cancer in its early stages. It also utilizes an ION Navigational platform to create a minimally invasive procedure for the evaluation of lung ...

The US Food and Drug Administration (FDA) has granted clearance to CureVac's investigational new drug application (IND) for ...

EU approves AstraZeneca’s Imfinzi-in combo with chemotherapy to treat patients with resectable non-small cell lung cancer ...